Protagenic Therapeutics exec chair Garo H. Armen acquires 26,291 common shares worth $4,805.99 - PTIX News | RalliesProtagenic Therapeutics exec chair Garo H. Armen acquires 26,291 common shares worth $4,805.99
P
PTIX• Insider purchase details
- Protagenic Therapeutics Executive Chair and Principal Officer Garo H. Armen bought 26,291 common shares in an open-market purchase.
- Purchase price was $0.18 per share.
- Armen reported direct ownership of 26,291 common shares following the transaction.
•
